Knight Therapeutics (TSE:GUD) Given Outperform Rating at Raymond James  Tech Know Bits

Knight Therapeutics (TSE:GUD)’s stock had its “outperform” rating reaffirmed by equities researchers at Raymond James in a research report issued to clients …